Last reviewed · How we verify
Nephrocheck test
At a glance
| Generic name | Nephrocheck test |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis) (NA)
- Effectiveness of the NephroCheck™ After TAVI
- Multicenter Assessment of a Bedside-testing System (Nephrocheck™) for Acute Kidney Injury After Thoracoabdominal Aortic Surgery
- Acute Kidney Attack in Severe Traumatized Patients
- Acute Kidney Injury After Cardiac Surgery (NA)
- Evaluation of AKI by Measuring the NephroCheck Test After Pediatric Cardiac Surgery
- Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients (PHASE4)
- Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nephrocheck test CI brief — competitive landscape report
- Nephrocheck test updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI